ProKidney Corp. (PROK) stock
PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.04−0.10 (-9.13%)
Close on Nov 13, 2026Market cap $315.93MP/E –Yield –
ProKidney total assets
Total assets on the balance sheet at the end of each period.
ProKidney's total assets was $210.28M at Sep 30, 2026. For fiscal 2025 it was $335.57M, down 23.9% from the year before. The highest annual figure on record is $518.00M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.57M | -23.9% |
| FY2024 | Dec 31, 2024 | $441.07M | +4.9% |
| FY2023 | Dec 31, 2023 | $420.55M | -18.8% |
| FY2022 | Dec 31, 2022 | $518.00M | +1185.4% |
| FY2021 | Dec 31, 2021 | $40.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $210.28M | -40.2% |
| Q2 FY2026 | Jun 30, 2026 | $249.02M | -33.1% |
| Q1 FY2026 | Mar 31, 2026 | $292.78M | -27.9% |
| Q4 FY2025 | Dec 31, 2025 | $335.57M | -23.9% |
| Q3 FY2025 | Sep 30, 2025 | $351.61M | -25.9% |
| Q2 FY2025 | Jun 30, 2025 | $372.13M | -25.4% |
| Q1 FY2025 | Mar 31, 2025 | $406.06M | +4.7% |
| Q4 FY2024 | Dec 31, 2024 | $441.07M | +4.9% |
| Q3 FY2024 | Sep 30, 2024 | $474.79M | +5.1% |
| Q2 FY2024 | Jun 30, 2024 | $499.16M | +3.1% |
| Q1 FY2024 | Mar 31, 2024 | $387.76M | -21.7% |
| Q4 FY2023 | Dec 31, 2023 | $420.55M | -18.8% |
| Q3 FY2023 | Sep 30, 2023 | $451.81M | -15.1% |
| Q2 FY2023 | Jun 30, 2023 | $484.22M | +92.9% |
| Q1 FY2023 | Mar 31, 2023 | $495.15M | +97.5% |
| Q4 FY2022 | Dec 31, 2022 | $518.00M | +1185.4% |
| Q3 FY2022 | Sep 30, 2022 | $532.44M | +111.8% |
| Q2 FY2022 | Jun 30, 2022 | $251.00M | +40202.1% |
| Q1 FY2022 | Mar 31, 2022 | $250.75M | – |
| Q4 FY2021 | Dec 31, 2021 | $40.30M | – |
| Q3 FY2021 | Sep 30, 2021 | $251.44M | – |
| Q2 FY2021 | Jun 30, 2021 | $622.80K | – |
See a number that looks wrong?